Killer peptide: A novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs

Walter Magliani, Stefania Conti, Tecla Ciociola, Laura Giovati, Pier Paolo Zanello, Thelma Pertinhez, Alberto Spisni, Luciano Polonelli

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The incidence of life-threatening viral and microbial infections has dramatically increased over recent decades. Despite significant developments in anti-infective chemotherapy, many issues have increasingly narrowed the therapeutic options, making it imperative to discover new effective molecules. Among them, small peptides are arousing great interest. This review will focus in particular on a killer peptide, engineered from an anti-idiotypic recombinant antibody that mimics the activity of a wide-spectrum antimicrobial yeast killer toxin targeting β-glucan cell-wall receptors. The in vitro and in vivo antimicrobial, antiviral and immunomodulatory activities of killer peptide and its ability to spontaneously and reversibly self-assemble and slowly release its active dimeric form over time will be discussed as a novel paradigm of targeted auto-delivering drugs.

Original languageEnglish
Pages (from-to)1209-1231
Number of pages23
JournalFuture Medicinal Chemistry
Volume3
Issue number9
DOIs
Publication statusPublished - Jul 2011

Fingerprint

Antiviral Agents
Peptides
Yeast Killer Factor
Pharmaceutical Preparations
Glucans
Virus Diseases
Cell Wall
Anti-Idiotypic Antibodies
Drug Therapy
Incidence
peptide A
Therapeutics
In Vitro Techniques

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Molecular Medicine

Cite this

Magliani, W., Conti, S., Ciociola, T., Giovati, L., Zanello, P. P., Pertinhez, T., ... Polonelli, L. (2011). Killer peptide: A novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs. Future Medicinal Chemistry, 3(9), 1209-1231. https://doi.org/10.4155/fmc.11.71

Killer peptide : A novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs. / Magliani, Walter; Conti, Stefania; Ciociola, Tecla; Giovati, Laura; Zanello, Pier Paolo; Pertinhez, Thelma; Spisni, Alberto; Polonelli, Luciano.

In: Future Medicinal Chemistry, Vol. 3, No. 9, 07.2011, p. 1209-1231.

Research output: Contribution to journalArticle

Magliani, W, Conti, S, Ciociola, T, Giovati, L, Zanello, PP, Pertinhez, T, Spisni, A & Polonelli, L 2011, 'Killer peptide: A novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs', Future Medicinal Chemistry, vol. 3, no. 9, pp. 1209-1231. https://doi.org/10.4155/fmc.11.71
Magliani, Walter ; Conti, Stefania ; Ciociola, Tecla ; Giovati, Laura ; Zanello, Pier Paolo ; Pertinhez, Thelma ; Spisni, Alberto ; Polonelli, Luciano. / Killer peptide : A novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs. In: Future Medicinal Chemistry. 2011 ; Vol. 3, No. 9. pp. 1209-1231.
@article{334d23107c3a4066b2b310a1ac9dab48,
title = "Killer peptide: A novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs",
abstract = "The incidence of life-threatening viral and microbial infections has dramatically increased over recent decades. Despite significant developments in anti-infective chemotherapy, many issues have increasingly narrowed the therapeutic options, making it imperative to discover new effective molecules. Among them, small peptides are arousing great interest. This review will focus in particular on a killer peptide, engineered from an anti-idiotypic recombinant antibody that mimics the activity of a wide-spectrum antimicrobial yeast killer toxin targeting β-glucan cell-wall receptors. The in vitro and in vivo antimicrobial, antiviral and immunomodulatory activities of killer peptide and its ability to spontaneously and reversibly self-assemble and slowly release its active dimeric form over time will be discussed as a novel paradigm of targeted auto-delivering drugs.",
author = "Walter Magliani and Stefania Conti and Tecla Ciociola and Laura Giovati and Zanello, {Pier Paolo} and Thelma Pertinhez and Alberto Spisni and Luciano Polonelli",
year = "2011",
month = "7",
doi = "10.4155/fmc.11.71",
language = "English",
volume = "3",
pages = "1209--1231",
journal = "Future Medicinal Chemistry",
issn = "1756-8919",
publisher = "Future Science",
number = "9",

}

TY - JOUR

T1 - Killer peptide

T2 - A novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs

AU - Magliani, Walter

AU - Conti, Stefania

AU - Ciociola, Tecla

AU - Giovati, Laura

AU - Zanello, Pier Paolo

AU - Pertinhez, Thelma

AU - Spisni, Alberto

AU - Polonelli, Luciano

PY - 2011/7

Y1 - 2011/7

N2 - The incidence of life-threatening viral and microbial infections has dramatically increased over recent decades. Despite significant developments in anti-infective chemotherapy, many issues have increasingly narrowed the therapeutic options, making it imperative to discover new effective molecules. Among them, small peptides are arousing great interest. This review will focus in particular on a killer peptide, engineered from an anti-idiotypic recombinant antibody that mimics the activity of a wide-spectrum antimicrobial yeast killer toxin targeting β-glucan cell-wall receptors. The in vitro and in vivo antimicrobial, antiviral and immunomodulatory activities of killer peptide and its ability to spontaneously and reversibly self-assemble and slowly release its active dimeric form over time will be discussed as a novel paradigm of targeted auto-delivering drugs.

AB - The incidence of life-threatening viral and microbial infections has dramatically increased over recent decades. Despite significant developments in anti-infective chemotherapy, many issues have increasingly narrowed the therapeutic options, making it imperative to discover new effective molecules. Among them, small peptides are arousing great interest. This review will focus in particular on a killer peptide, engineered from an anti-idiotypic recombinant antibody that mimics the activity of a wide-spectrum antimicrobial yeast killer toxin targeting β-glucan cell-wall receptors. The in vitro and in vivo antimicrobial, antiviral and immunomodulatory activities of killer peptide and its ability to spontaneously and reversibly self-assemble and slowly release its active dimeric form over time will be discussed as a novel paradigm of targeted auto-delivering drugs.

UR - http://www.scopus.com/inward/record.url?scp=79961099517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961099517&partnerID=8YFLogxK

U2 - 10.4155/fmc.11.71

DO - 10.4155/fmc.11.71

M3 - Article

C2 - 21806382

AN - SCOPUS:79961099517

VL - 3

SP - 1209

EP - 1231

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

SN - 1756-8919

IS - 9

ER -